The Biomarker Profile of Alzheimer's Disease for Disease-Modifying Treatment Eligibility: Questions and Debates.

Int J Mol Sci · 2025 · PMC12525501 · PMID 41096792

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

However, the recently published AA Clinical Practice Guideline suggested caution since there may be significant variability in their diagnostic accuracy and moderate confidence [ 174 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.